CYP21A2 and congenital adrenal hyperplasia: Given the frequency of CAH and its chimera-carrying alleles, which may involve the CYP21A2 and TNXB genes, early diagnosis of CAH-X is recommended to prevent and manage clinical manifestations in carriers of these alleles.